NCT01670773View on ClinicalTrials.gov

A Study of CAT-1004 Biomarkers in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Assessment of Mechanistic Blood Biomarkers in Healthy Humans
Interventions
DRUG

CAT-1004

DRUG

Salsalate + DHA

DRUG

Placebo

Trial Locations (1)

02135

ProMedica, Brighton

Sponsors
All Listed Sponsors
lead

Catabasis Pharmaceuticals

INDUSTRY

NCT01670773 - A Study of CAT-1004 Biomarkers in Healthy Subjects | Biotech Hunter | Biotech Hunter